FAQ: Ozempic and Weight Loss

Ozempic (semaglutide) has emerged as a noteworthy treatment not only for managing type 2 diabetes but also for aiding weight loss. As interest in this medication grows, so do questions about its effectiveness, safety, and practical implications. This article addresses frequently asked questions regarding Ozempic and its role in weight loss, supported by current research and clinical evidence.

What is Ozempic?

Ozempic is a GLP-1 receptor agonist medication approved by the FDA for the treatment of type 2 diabetes mellitus. It works by mimicking the effects of the naturally occurring hormone GLP-1, which helps regulate blood sugar levels. However, its influence on weight loss has garnered significant attention due to its additional benefits beyond glycemic control.

How does Ozempic promote weight loss?

The weight loss effects of Ozempic are attributed to several mechanisms:

  • Appetite Suppression: Ozempic acts on the brain's appetite control center, reducing feelings of hunger and promoting earlier feelings of fullness after meals.
  • Delayed Gastric Emptying: It slows down the rate at which food leaves the stomach, which can contribute to increased satiety and reduced calorie intake.
  • Improved Insulin Sensitivity: By enhancing insulin sensitivity and reducing insulin resistance, Ozempic helps the body utilize glucose more effectively and may facilitate weight loss.

What clinical evidence supports Ozempic's effectiveness for weight loss?

Clinical trials, particularly the STEP trials (Semaglutide Treatment Effect in People with Obesity), have demonstrated significant weight loss outcomes with Ozempic. Participants in these trials experienced average weight reductions ranging from 14% to 17% of their initial body weight over the course of 68 to 68 weeks. These results have established Ozempic as a potent option for individuals struggling with obesity, including those without diabetes.

Who is eligible to take Ozempic for weight loss?

Ozempic is primarily indicated for individuals with a BMI (Body Mass Index) of 27 kg/m² or higher who have at least one weight-related comorbidity (e.g., hypertension, dyslipidemia) or a BMI of 30 kg/m² or higher. It is generally prescribed to adults aged 18 years and older who have not achieved satisfactory weight loss through diet and exercise alone.

What are the potential side effects of Ozempic?

Common side effects of Ozempic include nausea, vomiting, diarrhea, constipation, and abdominal discomfort, particularly during the initial weeks of treatment. These side effects often improve as the body adjusts to the medication. Rare but serious side effects may include pancreatitis or kidney problems, so it's essential for patients to be monitored closely by their healthcare providers.

How long does it take to see results with Ozempic?

Individual responses to Ozempic can vary, but significant weight loss outcomes are typically observed within a few months of starting treatment. The medication is often prescribed as part of a comprehensive weight management plan that includes dietary changes and increased physical activity.

Can Ozempic be used long-term?

Long-term safety and efficacy data for Ozempic in the context of weight loss are still being studied. However, based on its established use in diabetes management and initial findings from obesity trials, Ozempic may be considered for long-term use under the supervision of a healthcare provider. Regular monitoring of weight, blood sugar levels, and potential side effects is recommended.

How does Ozempic compare to other weight loss medications?

Ozempic stands out among weight loss medications due to its dual benefits of improving glycemic control and promoting weight loss. While other medications may focus solely on appetite suppression or fat absorption inhibition, Ozempic's multifaceted approach makes it a versatile option for individuals with both diabetes and obesity.

Ozempic represents a significant advancement in the treatment of obesity, offering a dual benefit of weight loss and improved metabolic health. As with any medication, it's crucial for patients to discuss potential benefits, risks, and alternatives with their healthcare providers. Personalised treatment plans that include lifestyle modifications are essential for optimizing the outcomes of Ozempic therapy.


  • Flint A, Raben A, Astrup A, Holst JJ. Glucagon‐like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest. 1998;101:515‐520.
  • Gutzwiller JP, Drewe J, Goke B, et al. Glucagon‐like peptide‐1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol. 1999;276:R1541‐R1544.

To provide you with the best experience with Be Fit Food, we have ensured a range of documents are available to you including: Incident Management Policy, Complaints Management Policy and Complaints Management Form. If you need assistance with any of these documents, please contact our Customer Service team on 1300 263 257.